Srotaswini Mohapatra
Pune, 16 July 2024
The Study from York St. John University’s (YSJ) Centre for Applied Innovation (CAI) reveals that Base Molecular Resonance™ Technologies (BMRT) has the proven ability to transform the fields of public safety, law enforcement, security, military, and cancer detection with a simple scan. Developed by BMRT, this patented, one-of-a-kind molecular detection technology harnesses resonant frequencies to achieve unparalleled accuracy by non-invasively identifying substances, from explosives to cancerous tissues, both up close and at great distances.
The study, led by Professor Philippe B. Wilson, PhD, confirms BMRT’s detection capabilities to be 100% accurate for gunpowder, illegal drugs, nuclear elements, and cancerous tissues in both blind and double-blind tests.
Utilizing resonant frequencies at a subatomic level, BMR™ technology uniquely identifies molecular structures based on their nuclear composition. Professor Wilson highlights its pivotal role in enhancing security and medical diagnostics, noting its flawless detection without any false positives or negatives.
According to Professor Wilson, “Having assessed and evaluated BMRT’s technology, it is clear to me that I have never seen anything quite like it. Indeed, breakthrough technologies which can support every aspect of society are few and far between, leading to multinational success and Nobel Prize-worthy impact.”
According to Lee Duke, President & Co-Founder of BMRT, “BMR™ can detect elements of gunpowder encased in a single .22 caliber round of ammunition at a distance of 71 feet, the magazine clip of an AR-15 through multiple buildings at a distance of 580 feet, alert troops entering new and unknown areas to the presence of IEDs and other explosives, as well as armed enemy combatants. This technology allows us to detect those substances instantaneously and with 100% accuracy,” said Duke. “Early detection with BMR™ has the potential to identify would-be shooters before they enter a building, keep our troops safe no matter where they are located, and give law enforcement and military the information they need to save lives.”
Moreover, BMRT’s technology achieved breakthroughs in non-invasive cancer detection during blind and double-blind studies, accurately identifying breast and prostate cancers with no false positives or false negatives. While the study focused on breast and prostate cancers, BMRT has the capability to identify up to 200 types of cancers and other diseases as well.
Robert “Bo” Short, CEO and Co-Founder of BMRT emphasized, “These results confirm what we have known internally for some time: we can eliminate school shootings, late-stage cancer detection, illegal drugs crossing our borders or infiltrating our schools, and safely return our military personnel home without physical harm from lethal IEDs. In addition, there are aspects of this technology that are so highly sensitive and groundbreaking that we cannot even discuss them publicly. This patented technology can save millions of lives, billions of dollars and eliminate untold pain and suffering.”
